Sec31 refers to a protein that is part of the COPII complex, a critical component in the process of vesicular transport within eukaryotic cells. This complex is essential for transporting molecules from the endoplasmic reticulum (ER) to the Golgi apparatus, a key step in the secretory pathway of cells.Sec31 is a component of the outer coat of the COPII vesicle. It plays a vital role in the formation and budding of these transport vesicles from the ER. Specifically, Sec31 interacts with other COPII components, such as Sec13, Sec23, and Sec24, to assemble the vesicle coat. This coat encapsulates cargo molecules destined for transport and ensures their proper delivery to the Golgi apparatus.The function of Sec31 is not only structural but also regulatory. It is involved in selecting and packaging cargo molecules into vesicles, a process that requires precise recognition and binding of cargo proteins. Moreover, Sec31 has a role in determining the size of the COPII vesicles, which is crucial for accommodating different types of cargo.
Mutations or dysfunctions in the Sec31 protein or other components of the COPII complex can lead to transport defects. Such defects can disrupt normal cellular function and are associated with various diseases, including neural disorders and conditions related to protein misfolding and degradation.In summary, Sec31 is a critical component of the COPII vesicular transport complex, essential for the proper transport of proteins from the ER to the Golgi. Its role in vesicle formation, cargo selection, and size determination is crucial for maintaining efficient intracellular transport and overall cellular health.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts the Golgi apparatus and indirectly affects COPII vesicle formation. Its presence can alter the dynamics of Sec31 in the cell. | ||||||
XAV939 | 284028-89-3 | sc-296704 sc-296704A sc-296704B | 1 mg 5 mg 50 mg | $36.00 $117.00 $525.00 | 26 | |
ML141 is a Cdc42 inhibitor. Cdc42, a small GTPase, is involved in vesicle formation and trafficking. Its inhibition can indirectly influence Sec31 activity. | ||||||
Golgicide A | 1005036-73-6 | sc-215103 sc-215103A | 5 mg 25 mg | $191.00 $683.00 | 11 | |
This compound disrupts Golgi apparatus function and can indirectly affect Sec31's role in vesicle formation and trafficking. | ||||||
hydroxychloroquine | 118-42-3 | sc-507426 | 5 g | $57.00 | 1 | |
Known for its role in lysosomal pH increase, hydroxychloroquine can indirectly affect Sec31 by altering cellular trafficking pathways. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Monensin, an ionophore, disrupts Golgi function. This disruption can indirectly affect Sec31 activity in vesicle formation. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
A Dynamin inhibitor, Dynasore can indirectly influence Sec31 by affecting endocytic pathways and vesicle formation. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
This agent disrupts actin polymerization, potentially influencing vesicle trafficking and indirectly affecting Sec31 activity. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Nocodazole disrupts microtubule polymerization, which can influence vesicle trafficking and indirectly affect Sec31. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
An inhibitor of phosphoinositide 3-kinases, Wortmannin can affect vesicle trafficking, indirectly influencing Sec31 activity. | ||||||